PCM
CLPT icon

Parsons Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Parsons Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Sell
148,976
-194
-0.1% -$2.42K 0.12% 166
2026
Q1 		$1.36M Buy
149,170
+1,984
+1% +$25.1K 0.06% 232
2025
Q4 		$2.01M Buy
147,186
+4,450
+3% +$82.5K 0.11% 168
2025
Q3 		$3.11M Sell
142,736
-750
-0.5% -$8.84K 0.18% 126
2025
Q2 		$1.71M Buy
143,486
+950
+0.7% +$12K 0.11% 177
2025
Q1 		$1.69M Buy
142,536
+963
+0.7% +$15K 0.09% 190
2024
Q4 		$2.18M Buy
141,573
+2,600
+2% +$33.7K 0.12% 153
2024
Q3 		$1.56M Buy
138,973
+33,100
+31% +$317K 0.1% 182
2024
Q2 		$571K Hold
105,873
– – 0.04% 301
2024
Q1 		$720K Sell
105,873
-300
-0.3% -$2.1K 0.05% 273
2023
Q4 		$721K Hold
106,173
– – 0.05% 264
2023
Q3 		$532K Hold
106,173
– – 0.04% 283
2023
Q2 		$769K Buy
106,173
+9,400
+10% +$80K 0.06% 246
2023
Q1 		$817K Sell
96,773
-16,816
-15% -$147K 0.07% 239
2022
Q4 		$962K Buy
113,589
+3,919
+4% +$37.1K 0.08% 206
2022
Q3 		$1.14M Buy
109,670
+22
+0% +$290 0.1% 176
2022
Q2 		$1.43M Hold
109,648
– – 0.13% 158
2022
Q1 		$1.14M Sell
109,648
-674
-0.6% -$6.13K 0.09% 205
2021
Q4 		$1.24M Buy
110,322
+4,260
+4% +$63.8K 0.09% 199
2021
Q3 		$1.88M Buy
106,062
+2,450
+2% +$45.9K 0.15% 142
2021
Q2 		$1.98M Buy
103,612
+3,000
+3% +$58K 0.15% 146
2021
Q1 		$2.13M Sell
100,612
-37,172
-27% -$796K 0.17% 131
2020
Q4 		$2.19M Sell
137,784
-18,800
-12% -$169K 0.19% 115
2020
Q3 		$855K Buy
156,584
+5,000
+3% +$22K 0.08% 193
2020
Q2 		$539K Hold
151,584
– – 0.06% 226
2020
Q1 		$543K Buy
151,584
+124,961
+469% +$614K 0.07% 212
2019
Q4 		$128K Hold
26,623
– – 0.01% 339
2019
Q3 		$135K Buy
+26,623
New +$109K 0.01% 331

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Parsons Capital Management's CLPT Position: Q2 2026 in Review

Parsons Capital Management reduced its ClearPoint Neuro (CLPT) stake by 0.13% in Q2 2026, selling an estimated $2.42K and leaving 148,976 shares worth $2.66M. The position accounts for 0.12% of the portfolio, ranked #166.

Parsons Capital Management first reported a position in CLPT in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.11M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Parsons Capital Management held 148,976 shares of ClearPoint Neuro worth $2.66M as of Q2 2026.
  • Parsons Capital Management sold 194 ClearPoint Neuro shares in Q2 2026, an estimated $2.42K.
  • ClearPoint Neuro made up 0.12% of Parsons Capital Management's portfolio in Q2 2026, its #166 holding.
  • Parsons Capital Management first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 28 quarters since.
  • Parsons Capital Management's ClearPoint Neuro position peaked at $3.11M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.